Niu Nifang, Zhu Xilin, Liu Yang, Du Te, Wang Xin, Chen Dongmei, Sun Bei, Gu Harvest F, Liu Ying
National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, PR China.
Diabetes Metab Res Rev. 2007 Jan;23(1):21-5. doi: 10.1002/dmrr.641.
Dyslipidemia correlating to insulin resistance is one of the key features in type 2 diabetes (T2D). Recent studies have demonstrated that apolipoprotein M (apoM) is important for the formation of prebeta-high-density lipoprotein (HDL) and cholesterol (CHO) efflux in macrophages to HDL. In the present study, we investigated the potential association of apoM genetic variation with the development of T2D.
Single nucleotide polymorphisms (SNPs) C-1065A, T-855C and T-778C in the proximal promoter region of apoM gene were validated to represent in Han Chinese. Further genotyping experiments in 170 T2D patients and 156 non-diabetic control subjects were performed with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
Single marker analysis for SNP T-778C indicated that T2D patients had increased frequency of C allele in comparison with non-diabetic controls (10.6% versus 5.8%, P = 0.026, OR = 1.934). In non-diabetic controls, the carriers with CT and CC genotypes had higher plasma CHO (221.7 versus 204.2 mg/dL, P = 0.033) and fasting plasma glucose (FPG) (92.6 versus 89.7 mg/dL, P = 0.041) levels than the subjects with TT genotype. Further analysis with adjustment for age, BMI, SBP, DBP, CHO and TG demonstrated that this SNP was strongly associated with T2D (P = 0.013, OR = 2.287). Haplotype analysis for those three SNPs, however, indicated that the common haplotypes were less informative than studying the role of the T-778C variant independently of the haplotype context.
The present study provided the first evidence that SNP T-778C in the proximal promoter region of apoM gene was associated with the levels of plasma CHO and FPG and also conferred the risk in the development of T2D among Han Chinese.
与胰岛素抵抗相关的血脂异常是2型糖尿病(T2D)的关键特征之一。最近的研究表明,载脂蛋白M(apoM)对前β-高密度脂蛋白(HDL)的形成以及巨噬细胞中胆固醇(CHO)向HDL的流出很重要。在本研究中,我们调查了apoM基因变异与T2D发生之间的潜在关联。
验证了apoM基因近端启动子区域的单核苷酸多态性(SNP)C-1065A、T-855C和T-778C在汉族人群中的代表性。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)对170例T2D患者和156例非糖尿病对照者进行进一步基因分型实验。
对SNP T-778C的单标记分析表明,与非糖尿病对照者相比,T2D患者中C等位基因的频率增加(10.6%对5.8%,P = 0.026,OR = 1.934)。在非糖尿病对照者中,CT和CC基因型携带者的血浆CHO水平(221.7对204.2mg/dL,P = 0.033)和空腹血糖(FPG)水平(92.6对89.7mg/dL,P = 0.041)高于TT基因型受试者。在对年龄、BMI、收缩压、舒张压、CHO和甘油三酯进行校正后的进一步分析表明,该SNP与T2D密切相关(P = 0.013,OR = 2.287)。然而,对这三个SNP的单倍型分析表明,常见单倍型的信息量不如独立于单倍型背景研究T-778C变异体的作用。
本研究首次提供证据表明,apoM基因近端启动子区域的SNP T-778C与血浆CHO和FPG水平相关,并增加了汉族人群发生T2D的风险。